RORoche Holding AG
379.60CHF+0.96%Mkt Cap: 341.92B $P/E: 24.51

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas o…

Key Statistics

Company
Market Cap341.92B $
Enterprise Value373.41B $
Revenue (TTM)71.86B $
Gross Profit53.31B $
Net Income (TTM)14.70B $
Revenue/Share90.27 USD
Last Price379.60 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - General
ISINCH0012032048
Valuation
P/E (Trailing)24.51
P/E (Forward)16.96
PEG1.68
EV/EBITDA13.65
EV/Revenue5.20
P/S4.71
P/B9.07
EPS (TTM)15.34
EPS (Forward)21.94
52W Range
260.6097% of range383.00
52W High383.00 CHF
52W Low260.60 CHF
Profitability
Gross Margin73.73%
Oper. Margin36.20%
EBITDA Margin38.06%
Profit Margin20.33%
ROE38.10%
ROA12.79%
Growth
Revenue Growth-1.20%
Earnings Growth-7.70%
Cash Flow & Leverage
Operating CF21.52B $
CapEx (TTM)6.60B $
FCF Margin16.39%
FCF Yield3.44%
Net Debt26.91B $
Net Debt/EBITDA0.98
Balance Sheet
Debt/Equity0.98
Current Ratio1.23
Quick Ratio0.80
Book Value/Sh41.03 CHF
Cash/Share12.22 CHF
Dividends
Fwd Div Rate9.800 CHF
Trail. Div Rate9.800 CHF
Div. Yield2.63%
5Y Avg Yield3.06%
Payout Ratio63.93%
Ex-Div DateMar 12, 2026
Pay DateMar 31, 2025
Splits
Last Split100:1
Split DateMay 4, 2011
Analyst Consensus
Rating
Target (Mean)367.00 CHF
Upside (mean)-3.3%
Target Range340.00 CHF396.00 CHF
CHF340.00-3.3% to meanCHF396.00
# Analysts3
Ownership
Shares Out.106.69M
Float654.09M
Insiders72.31%
Institutions10.96%
Technical
SMA 50348.60 (+8.9%)
SMA 200339.28 (+11.9%)
Beta0.35
S&P 52W Chg18.16%
Avg Vol (30d)20.52K
Avg Vol (10d)18.26K
Technical Indicators
RSI (14)62.9
MACD7.3152
MACD Signal7.6467
MACD Hist.-0.3316
BB Upper384.52 CHF
BB Middle365.87 CHF
BB Lower347.22 CHF
BB Width10.19%
ATR (14)7.456 CHF
Vol Ratio (20d)0.81x